Elsie Biotechnologies
Elsie Biotechnologies, now part of GSK, carried the lab’s P(V) chemistry toward oligonucleotide medicines; its scientists co-authored the P(V) oligonucleotide platform and its improved successor.
San Diego, California · A GSK company since 2024
- Papers together
- 3
- Years
- 2021–2025
- Co-authors
- 12
All 3 papers with Elsie Biotechnologies
-
An Improved P(V) Thio-Oligonucleotide Synthesis Platform
- Elsie Biotechnologies Kyle W. Knouse, Richard L. Redman, Yonghao Jin
- Hongene Biotech David Butler, Yang Yang, Yao Feng
- Socrates Biosciences Arjun Natarajan
-
Nature Chose Phosphates and Chemists Should Too: How Emerging P(V) Methods Can Augment Existing Strategies
- Bristol Myers Squibb Ivar M. McDonald, Martin D. Eastgate, Michael A. Schmidt
- Elsie Biotechnologies Dillon T. Flood, Kyle W. Knouse
-
A P(V) Platform for Oligonucleotide Synthesis
- Bristol Myers Squibb Bin Zheng, Ivar M. McDonald, Martin D. Eastgate, Michael A. Schmidt, Richard E. Olson, Shenjie Qiu, Stephen E. Mercer, Yazhong Huang
- Elsie Biotechnologies Bin Zheng, Ivar M. McDonald, Kyle W. Knouse, Martin D. Eastgate, Michael A. Schmidt, Richard E. Olson, Shenjie Qiu, Stephen E. Mercer, Yazhong Huang
No papers match these filters.
Our co-authors at Elsie Biotechnologies
Martin D. Eastgate · Dillon T. Flood · Yazhong Huang · Yonghao Jin · Kyle W. Knouse · Ivar M. McDonald · Stephen E. Mercer · Richard E. Olson · Shenjie Qiu · Richard L. Redman · Michael A. Schmidt · Bin Zheng
Some of these papers were shared with 3 other partners: Hongene Biotech, Socrates Biosciences, Bristol Myers Squibb.
More partners
Enamine
HitGen Hongene Biotech Hongene Biotech IKA IKA InduPro Therapeutics InduPro Therapeutics
KULR Technology RQx Pharmaceuticals RQx Pharmaceuticals Socrates Biosciences Socrates Biosciences The Medicines Company The Medicines Company Interested in collaborating with the Baran lab?
If your team has a problem that matters, a molecule no one can make, a reaction that will not scale, a reagent that should exist, we would love to hear about it.
Email Philor write to pbaran@scripps.edu


